Publications

5491 Results

Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals

Authors
H Chen;A Majumdar;L Wang;S Kar;K Brown;H Feng;P Pharoah;R Hung;L Amundadottir;P Kraft;B Pasaniuc;S Lindstrom;Consortium GECCO (C Tangen)
Journal / Conference
HGG Advances Jul 8;2(3):100041
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID34355204
PMC
PMC8336922
Study Number(s)
S0000

Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial

Authors
C Paoletti;W Barlow;E Cobain;M Bergqvist;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
Journal / Conference
Clinical Cancer Research, Nov 15;27(22):6115-6123
Year
2021
Research Committee(s)
Breast
PMC
PMID34521624
Study Number(s)
S0226

Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years

Authors
E Cathcart-Rake;K Ruddy;WA Bleyer;R Johnson
Journal / Conference
JCO Oncology Practice, Jun;17(6):305-313
Year
2021
Research Committee(s)
Cancer Care Delivery
PMID
PMID33449828

Clinical and Scientific Impact of National Cancer Institute-Sponsored Clinical Trial Network Group Treatment Trials

Authors
JM Unger;M Leblanc;M Bertagnolli;N Wolmark;W Curran;P O Dwyer;M Schnall;R Mannel;S Mandrekar;J Costantino;R Gray;F Zhao;F Hong;M Bah;R Vaidya;CD Blanke
Journal / Conference
Annals of Oncology 32 (suppl_5): S1102-S1110 (ESMO Annual Meeting (September 16-21, 2021), oral session, abst #1503O
Year
2021
Research Committee(s)
Cancer Care Delivery

Granulomatous and sarcoid-like immune related adverse events (irAEs) following CTLA4 and PD1 blockade adjuvant therapy of high-risk melanoma: A combined analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials

Authors
A Noor;I Yassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
Annals of Oncology 32 (suppl_5): S867-S905. 10.1016/annonc/annonc706ESMO Annual Meeting (September 16-21, 2021), accepted, E-poster presentation abst #1069P
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609, S1404

Quality of life (QOL) endpoints of the Phase III Intergroup S1404 adjuvant melanoma trial

Authors
SP Patel;M Othus;A Darke;K Stevinson;E Sharon;V Sondak;A Ribas;K Grossmann
Journal / Conference
Annals of Oncology (2021) 32 (suppl_5): S867-S905 (ESMO Annual Meeting (September 16-21, 2021), accepted, E-poster, abst# 1073P)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
S1404

Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Authors
M Rock;R Vaidya;C Till;J Unger;D Hershman;C Tangen;D Maeng;R Krouse
Journal / Conference
Journal of Clinical Oncology 39, 2021 (suppl 28; abstr 144) (ASCO Quality Care Symposium (Sept 24-25, 2021), poster)
Year
2021
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000

Hope-enhancement workshops in the SWOG Cancer Research Network: Feasibility of an online intervention

Authors
D Feldman;M O'Rourke;D Corn;I Subbiah;M Manasseh;M Hudson;R Agarwal;M Bakitas;V Fraser;L Fowler;B Corn
Journal / Conference
J Clin Oncol 39 (suppl 28; abstr 210) (ASCO Quality Care Symposium (Sept 24-25, 2021)) poster
Year
2021

S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma

Authors
A Tsao;L Qian;J Cetnar;B Sepesi;D Gomez;J Wrangle;G Simon;F Mott;R Hall;R Santana-Davila;M Koczywas;M Redman;K Kelly
Journal / Conference
WCLC World Conference on Lung Cancer (September 8-14, 2021, virtual), oral, Abst #OA13.01
Year
2021
Research Committee(s)
Lung
Study Number(s)
S1619

Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients in The U.S. ALCHEMIST Study (Alliance)

Authors
K Kehl;D Zahrieh;P Yang;S Hillman;A Tan;J Sands;G Oxnard;E Gillespie;D Wigle;S Malik;T Stinchcombe;S Ramalingam;K Kelly;S Mandrekar;R Osarogiagbon;D Kozono
Journal / Conference
WCLC World Conference on Lung Cancer (September 8-14, 2021, virtual), mini-oral, #MA15.05
Year
2021
Research Committee(s)
Lung
Study Number(s)
CTSU/A151216